Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cabot (CBT) Gains from Sales and Divestitures (2022 - 2025)

Cabot (CBT) reported Gains from Sales and Divestitures of $292000.0 for Q3 2025, down 38.91% year-over-year from $478000.0 in Q3 2024, and down 38.91% on a QoQ basis from $478000.0 in Q3 2024.

Cabot (CBT) has 4 years of Gains from Sales and Divestitures data on file, last reported at $292000.0 in Q3 2025.

  • Quarterly Gains from Sales and Divestitures fell 38.91% year-over-year to $292000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $292000.0 (down 38.91% YoY) and the FY2025 annual result came in at $292000.0, down 38.91% from the prior year.
  • Gains from Sales and Divestitures eased to $292000.0 in Q3 2025 per CBT's latest filing, from $478000.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $478000.0 in Q3 2024 and bottomed at $213000.0 in Q3 2022.
  • The 4-year median for Gains from Sales and Divestitures is $283500.0 (2023), against an average of $314500.0.
  • The widest annual swing landed in 2024, when Gains from Sales and Divestitures surged 73.82%; it then slumped 38.91% in 2025.
  • Tracing CBT's Gains from Sales and Divestitures over 4 years: stood at $213000.0 in 2022, then grew by 29.11% to $275000.0 in 2023, then soared by 73.82% to $478000.0 in 2024, then tumbled by 38.91% to $292000.0 in 2025.
  • Per Business Quant, the three latest CBT Gains from Sales and Divestitures figures stand at $292000.0 (Q3 2025), $478000.0 (Q3 2024), and $275000.0 (Q3 2023).

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 292,000.00
Sep 30, 2025 292,000.00
Sep 30, 2024 478,000.00
Sep 30, 2024 478,000.00
Sep 30, 2023 275,000.00
Sep 30, 2023 275,000.00
Sep 30, 2022 213,000.00
Sep 30, 2022 213,000.00